Correlation Between RenovoRx and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on RenovoRx and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Acrivon Therapeutics,.
Diversification Opportunities for RenovoRx and Acrivon Therapeutics,
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between RenovoRx and Acrivon is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of RenovoRx i.e., RenovoRx and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between RenovoRx and Acrivon Therapeutics,
Given the investment horizon of 90 days RenovoRx is expected to generate 1.17 times more return on investment than Acrivon Therapeutics,. However, RenovoRx is 1.17 times more volatile than Acrivon Therapeutics, Common. It trades about 0.03 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest 190.00 in RenovoRx on August 29, 2024 and sell it today you would lose (54.00) from holding RenovoRx or give up 28.42% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
RenovoRx vs. Acrivon Therapeutics, Common
Performance |
Timeline |
RenovoRx |
Acrivon Therapeutics, |
RenovoRx and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with RenovoRx and Acrivon Therapeutics,
The main advantage of trading using opposite RenovoRx and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.RenovoRx vs. Eliem Therapeutics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals | RenovoRx vs. Seres Therapeutics |
Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals | Acrivon Therapeutics, vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |